Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
September 8, 2015
0Patent Application Number
133651600
Date Filed
February 2, 2012
0Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided are compositions and methods for the treatment of macular edema, in particular that results from central retinal vein occlusion (CRVO), branch retinal vein occlusion (BRVO), age related macular degeneration (AMD), diabetes, or eye surgical procedures. The composition strengthens retinal health through the prevention, stabilization and/or treatment of macular edema. The composition can include polyphenolic compounds extracted from natural plants, an alpha lipoic acid, docosahexaenoic acid (DHA) and/or eicosapentaenoic acid (EPA), and ubiquinone.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
